As you may have heard, the Israeli Parliament passed an amendment on December 25th that concerns the governance and regulatory aspects of exporting medical cannabis from Israel. This bill paves the way for Seedo to export medical grade cannabis, cultivated and grown by their commercial auto-growing facility, manufactured for the industrial sector.
“Israel is a medical cannabis power,” said Minister of Agriculture Uri Ariel, “The Israeli research conditions for growth in the field precede most of the countries in the world by 5-7 years because of progressive regulation.”
“Furthermore, the products in Israel are manufactured according to strict production standards, on a medical level, like in the pharmaceutical industry – including strict security rules for the entire value chain, developed following inter-ministerial work which took place over a prolonged period of time.”
Seedo is well positioned to take advantage of this legislation towards exporting medical grade cannabis, cultivated and grown by Seedo’s commercial auto-growing facility, which Seedo manufactures for the industrial sector.
The Automated growing facility is remotely controlled by algorithms that take into consideration multiple variables parameters data from within the facility. The automated growth ensures maximum yield of pesticide-free, high-quality medical grade cannabis which can be then processed and exported from Israel.
“This new legislation removes the last legal obstacle which remained in the path towards approving export and singing it into Israeli law,” Said Zohar Levy, CEO of Seedo. “By the end of the year 2019, Israeli companies will be able to take advantage of our edge technology and leverage the possibility to export high quality, pesticide-free medical cannabis to the world. We are proud to be able to offer this solution to the local Israeli and international growers.”